A synthetic lethal screen identifies FAT1 as an antagonist of caspase-8 in extrinsic apoptosis

The extrinsic apoptosis pathway is initiated by binding of death ligands to death receptors resulting in the formation of the death‐inducing signaling complex (DISC). Activation of procaspase‐8 within the DISC and its release from the signaling complex is required for processing executor caspases and commiting cell death. Here, we report that the atypical cadherin FAT1 interacts with caspase‐8 preventing the association of caspase‐8 with the DISC. We identified FAT1 in a genome‐wide siRNA screen for synthetic lethal interactions with death receptor‐mediated apoptosis. Knockdown of FAT1 sensitized established and patient‐derived glioblastoma cell lines for apoptosis transduced by cell death ligands. Depletion of FAT1 resulted in enhanced procaspase‐8 recruitment to the DISC and increased formation of caspase‐8 containing secondary signaling complexes. In addition, FAT1 knockout cell lines generated by CRISPR/Cas9‐mediated genome engineering were more susceptible for death receptor‐mediated apoptosis. Our findings provide evidence for a mechanism to control caspase‐8‐dependent cell death by the atypical cadherin FAT1. These results contribute towards the understanding of effector caspase regulation in physiological conditions.

[1]  C. Sarkar,et al.  FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells , 2013, Oncogene.

[2]  C. Barbas,et al.  ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.

[3]  G. Peters,et al.  Non-canonical kinase signaling by the death ligand TRAIL in cancer cells: discord in the death receptor family , 2013, Cell Death and Differentiation.

[4]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[5]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[6]  L. Liau,et al.  Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation , 2013, Nature Genetics.

[7]  D. Lawrence,et al.  TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8 with a ubiquitin shutoff timer. , 2012, Molecular cell.

[8]  Thomas Horn,et al.  GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update , 2012, Nucleic Acids Res..

[9]  Louise Fairall,et al.  A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death , 2012, Molecular cell.

[10]  Inna N Lavrik,et al.  Stoichiometry of the CD95 death-inducing signaling complex: experimental and modeling evidence for a death effector domain chain model. , 2012, Molecular cell.

[11]  L. Goodrich,et al.  Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity , 2012, Development.

[12]  R. Thorne,et al.  The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis–relapse samples of precursor B-cell acute lymphoblastic leukemia , 2012, Leukemia.

[13]  K. Nakashiro,et al.  Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of β-catenin. , 2011, Oncology reports.

[14]  G. Häcker,et al.  cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP Isoforms , 2011, Molecular cell.

[15]  T. Tenev,et al.  The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. , 2011, Molecular cell.

[16]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[17]  A. Ashkenazi,et al.  New insights into apoptosis signaling by Apo2L/TRAIL , 2010, Oncogene.

[18]  Pascal Meier,et al.  IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer , 2010, Nature Reviews Cancer.

[19]  Oliver Pelz,et al.  web cellHTS2: A web-application for the analysis of high-throughput screening data , 2010, BMC Bioinformatics.

[20]  H. Gollnick,et al.  Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitment , 2009, The Journal of cell biology.

[21]  H. Schägger,et al.  Native electrophoretic techniques to identify protein–protein interactions , 2009, Proteomics.

[22]  M. Butterworth,et al.  Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. , 2009, Molecular cell.

[23]  S. Fulda,et al.  Adhesion-mediated apoptosis resistance in cancer. , 2009, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[24]  D. Lawrence,et al.  Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling , 2009, Cell.

[25]  N. Sibinga,et al.  Atrophin Proteins Interact with the Fat1 Cadherin and Regulate Migration and Orientation in Vascular Smooth Muscle Cells* , 2009, Journal of Biological Chemistry.

[26]  Ya-xi Zhang,et al.  Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL)‐induced chemokine release in both TRAIL‐resistant and TRAIL‐sensitive cells via nuclear factor kappa B , 2009, The FEBS journal.

[27]  S. Fulda,et al.  Identification of a novel switch in the dominant forms of cell adhesion-mediated drug resistance in glioblastoma cells , 2008, Oncogene.

[28]  A. Ashkenazi,et al.  Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  D. Vaux,et al.  TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1–TRAF2 complex to sensitize tumor cells to TNFα , 2008, The Journal of cell biology.

[30]  Michael Boutros,et al.  The art and design of genetic screens: RNA interference , 2008, Nature Reviews Genetics.

[31]  G. Cavet,et al.  Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL , 2007, Nature Medicine.

[32]  Inna N. Lavrik,et al.  Life and death in peripheral T cells , 2007, Nature Reviews Immunology.

[33]  A. Unterberg,et al.  Different angiogenic phenotypes in primary and secondary glioblastomas , 2006, International journal of cancer.

[34]  Andreas Untergasser,et al.  Preclinical Differentiation between Apparently Safe and Potentially Hepatotoxic Applications of TRAIL Either Alone or in Combination with Chemotherapeutic Drugs , 2006, Clinical Cancer Research.

[35]  A. Leong,et al.  Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis? , 2006, Pathology.

[36]  D. Lawrence,et al.  Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand* , 2005, Journal of Biological Chemistry.

[37]  M. Takeichi,et al.  New insights into Fat cadherins , 2005, Journal of Cell Science.

[38]  David L. Vaux,et al.  IAPs, RINGs and ubiquitylation , 2005, Nature Reviews Molecular Cell Biology.

[39]  L. Holzman,et al.  Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization , 2004, The EMBO journal.

[40]  T. Kang,et al.  Caspase-8 Serves Both Apoptotic and Nonapoptotic Roles1 , 2004, The Journal of Immunology.

[41]  S. Baumgartner,et al.  The fat-like Gene of Drosophila Is the True Orthologue of Vertebrate Fat Cadherins and Is Involved in the Formation of Tubular Organs* , 2004, Journal of Biological Chemistry.

[42]  M. Takeichi,et al.  Mammalian Fat1 cadherin regulates actin dynamics and cell–cell contact , 2004, The Journal of cell biology.

[43]  M. Peter,et al.  Interdimer processing mechanism of procaspase‐8 activation , 2003, The EMBO journal.

[44]  S. Korsmeyer,et al.  VDAC2 Inhibits BAK Activation and Mitochondrial Apoptosis , 2003, Science.

[45]  J. Tschopp,et al.  Induction of TNF Receptor I-Mediated Apoptosis via Two Sequential Signaling Complexes , 2003, Cell.

[46]  C. ffrench-Constant,et al.  Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia Phenotype , 2003, Molecular and Cellular Biology.

[47]  D. Green,et al.  A unified model for apical caspase activation. , 2003, Molecular cell.

[48]  P. Krammer,et al.  FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.

[49]  G. Pari,et al.  Bifunctional protein conferring enhanced green fluorescence and puromycin resistance. , 2001, BioTechniques.

[50]  J. Blenis,et al.  FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. , 2000, Immunity.

[51]  J. Dichgans,et al.  Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. , 1999, Biochemical and biophysical research communications.

[52]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[53]  J. Blenis,et al.  Essential requirement for caspase-8/FLICE in the initiation of the Fas-induced apoptotic cascade , 1998, Current Biology.

[54]  J. Beckmann,et al.  Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. , 1998, Immunity.

[55]  M. Peter,et al.  Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.

[56]  R. Siegel,et al.  Membrane Oligomerization and Cleavage Activates the Caspase-8 (FLICE/MACHα1) Death Signal* , 1998, The Journal of Biological Chemistry.

[57]  Brent R. Stockwell,et al.  An Induced Proximity Model for Caspase-8 Activation* , 1998, The Journal of Biological Chemistry.

[58]  Matthias Mann,et al.  FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex , 1996, Cell.

[59]  S. Marsters,et al.  Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family* , 1996, The Journal of Biological Chemistry.

[60]  C A Smith,et al.  Identification and characterization of a new member of the TNF family that induces apoptosis. , 1995, Immunity.

[61]  M. Peter,et al.  Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. , 1995, The EMBO journal.

[62]  Peter J. Bryant,et al.  The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily , 1991, Cell.

[63]  B. Aggarwal,et al.  Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. , 1985, Science.

[64]  G. Gores,et al.  Cellular inhibitor of apoptosis 1 (cIAP-1) degradation by caspase 8 during TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. , 2011, Experimental cell research.

[65]  西川 由希子.  Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of β-catenin , 2011 .

[66]  H. Walczak,et al.  Biochemical analysis of the native TRAIL death-inducing signaling complex. , 2008, Methods in molecular biology.

[67]  Vishva M Dixit,et al.  IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. , 2007, Cell.

[68]  C. Hawkins.  TRAIL and malignant glioma. , 2004, Vitamins and hormones.

[69]  Jeffry D Sander,et al.  FLAsH assembly of TALeNs for high-throughput genome editing , 2022 .